ArticleJournal of internal medicine2023

Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis.

Binu V John et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.